经济观察网昊海生物科技近期最受关注的事件是股东减持计划。2026年2月12日,公司公告股东楼国梁因自身资金需要,计划在公告披露后3个交易日起的3个月内,通过集中竞价和大宗交易方式减持不超过100万股股份,占公司总股本比例不超过0.4337%。该减持计划可能对短期市场情绪构成压力,但符合股东此前的上市承诺。股票近期走势股价方面,昊海生科A股(688366.SH)近期表现偏弱。截至2026年2月13日...
Source Link经济观察网昊海生物科技近期最受关注的事件是股东减持计划。2026年2月12日,公司公告股东楼国梁因自身资金需要,计划在公告披露后3个交易日起的3个月内,通过集中竞价和大宗交易方式减持不超过100万股股份,占公司总股本比例不超过0.4337%。该减持计划可能对短期市场情绪构成压力,但符合股东此前的上市承诺。股票近期走势股价方面,昊海生科A股(688366.SH)近期表现偏弱。截至2026年2月13日...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.